Hai‐Bing Zhou

3.4k total citations
128 papers, 2.8k citations indexed

About

Hai‐Bing Zhou is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Hai‐Bing Zhou has authored 128 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 56 papers in Organic Chemistry and 40 papers in Genetics. Recurrent topics in Hai‐Bing Zhou's work include Estrogen and related hormone effects (40 papers), Protein Degradation and Inhibitors (19 papers) and Asymmetric Synthesis and Catalysis (15 papers). Hai‐Bing Zhou is often cited by papers focused on Estrogen and related hormone effects (40 papers), Protein Degradation and Inhibitors (19 papers) and Asymmetric Synthesis and Catalysis (15 papers). Hai‐Bing Zhou collaborates with scholars based in China, United States and Hong Kong. Hai‐Bing Zhou's co-authors include Chune Dong, Xin Han, John A. Katzenellenbogen, Jian Huang, Zhiye Hu, Kathryn E. Carlson, Benita S. Katzenellenbogen, K.W. Nettles, Chu Tang and Shuwen Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Chemical Communications.

In The Last Decade

Hai‐Bing Zhou

125 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hai‐Bing Zhou China	31	1.4k	1.1k	584	352	294	128	2.8k
Jeffrey A. Dodge United States	31	1.1k 0.8×	1.4k 1.2×	842 1.4×	364 1.0×	205 0.7×	68	3.4k
Jay Wrobel United States	33	1.5k 1.0×	876 0.8×	399 0.7×	410 1.2×	127 0.4×	76	2.8k
Zhihua Sui United States	28	1.5k 1.1×	949 0.8×	236 0.4×	215 0.6×	167 0.6×	123	2.7k
Todd K. Jones United States	33	1.9k 1.4×	961 0.8×	463 0.8×	127 0.4×	296 1.0×	63	3.0k
Yosuke Demizu Japan	33	1.6k 1.2×	2.7k 2.3×	149 0.3×	529 1.5×	218 0.7×	235	4.0k
Zhaopeng Liu China	25	869 0.6×	849 0.7×	135 0.2×	241 0.7×	154 0.5×	127	2.1k
Gervais Bérubé Canada	27	1.2k 0.9×	1.3k 1.2×	206 0.4×	742 2.1×	61 0.2×	98	2.6k
Allan M. Jordan United Kingdom	27	2.7k 1.9×	2.5k 2.2×	100 0.2×	515 1.5×	500 1.7×	61	4.9k
Shilong Zheng United States	29	935 0.7×	1.2k 1.0×	174 0.3×	409 1.2×	58 0.2×	79	2.3k
Martin Rowlands United Kingdom	29	637 0.5×	1.5k 1.3×	538 0.9×	273 0.8×	37 0.1×	67	2.6k

Countries citing papers authored by Hai‐Bing Zhou

Since Specialization

Citations

This map shows the geographic impact of Hai‐Bing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai‐Bing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai‐Bing Zhou more than expected).

Fields of papers citing papers by Hai‐Bing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai‐Bing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai‐Bing Zhou. The network helps show where Hai‐Bing Zhou may publish in the future.

Co-authorship network of co-authors of Hai‐Bing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hai‐Bing Zhou. A scholar is included among the top collaborators of Hai‐Bing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai‐Bing Zhou. Hai‐Bing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Dandan, Yihe Wu, Xuelian Liu, et al.. (2024). Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer. European Journal of Medicinal Chemistry. 275. 116572–116572. 9 indexed citations

Tan, Yuxin, Qian Wang, Rong Xu, et al.. (2024). FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia. Cancer Letters. 592. 216933–216933. 12 indexed citations

Shen, Rong, et al.. (2024). OBHSA, a novel selective estrogen receptor degrader, overcomes tamoxifen resistance through cell cycle arrest and unfolded protein response-mediated apoptosis in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 244. 106599–106599. 1 indexed citations

Yang, Chunmei, et al.. (2024). A novel photostable near-infrared fluorescent selective estrogen receptor modulator (SERM) for live-cell 3D imaging of breast cancer. Sensors and Actuators B Chemical. 407. 135454–135454. 2 indexed citations

Li, Jiahao, Yang Lu, Yi Yu, et al.. (2024). A Drug Molecule-Modified Graphene Field-Effect Transistor Nanosensor for Rapid, Label-Free, and Ultrasensitive Detection of Estrogen Receptor α Protein. Analytical Chemistry. 96(8). 3454–3461. 7 indexed citations

Deng, Xiaofei, et al.. (2024). Novel estrogen receptor β/histone deacetylase dual-targeted near-infrared fluorescent probes as theranostic agents for imaging and treatment of prostate cancer. European Journal of Medicinal Chemistry. 268. 116236–116236. 4 indexed citations

Yin, Zhinang, Honghong Wang, Conghui Li, et al.. (2023). CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. Science Advances. 9(20). eadf8698–eadf8698. 13 indexed citations

Deng, Xiaofei, Zhiye Hu, Kaiwei Liang, et al.. (2023). Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 66(16). 11094–11117. 17 indexed citations

Yin, Zhinang, Zhiye Hu, Yuan Huang, et al.. (2023). Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo. Journal of Medicinal Chemistry. 66(10). 6631–6651. 20 indexed citations

10.

Hu, Zhiye, Xiaofei Deng, Pingping Fang, et al.. (2022). Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 65(11). 7993–8010. 27 indexed citations

11.

Yang, Liang, et al.. (2021). Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment. European Journal of Medicinal Chemistry. 229. 114081–114081. 17 indexed citations

12.

Meng, Qiuyu, Xiaoyu Ma, Zhiye Hu, et al.. (2020). Rational design of ERα targeting hypoxia turn-on fluorescent probes with antiproliferative activity for breast cancer. Chemical Communications. 56(72). 10493–10496. 10 indexed citations

13.

Hu, Zhiye, Yuanyuan Li, Yuan Huang, et al.. (2019). Novel class of 7-Oxabicyclo[2.2.1]heptene sulfonamides with long alkyl chains displaying improved estrogen receptor α degradation activity. European Journal of Medicinal Chemistry. 182. 111605–111605. 14 indexed citations

14.

Li, Yuanyuan, Silong Zhang, Jing Zhang, et al.. (2019). Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs). European Journal of Medicinal Chemistry. 172. 48–61. 34 indexed citations

15.

Hu, Zhiye, Jing Zhang, Silong Zhang, et al.. (2019). Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators. Chemical Communications. 55(97). 14570–14573. 11 indexed citations

16.

Hu, Zhiye, Chu Tang, Lu Yang, et al.. (2018). Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer. Journal of Medicinal Chemistry. 61(18). 8155–8173. 35 indexed citations

17.

Hu, Zhiye, Lu Yang, Chu Tang, et al.. (2018). A high-affinity subtype-selective fluorescent probe for estrogen receptor β imaging in living cells. Chemical Communications. 54(31). 3887–3890. 18 indexed citations

18.

Tang, Qi, Zhichao Xu, Mengyu Jin, et al.. (2018). Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors. European Journal of Medicinal Chemistry. 159. 206–216. 13 indexed citations

19.

Zhou, Hai‐Bing, et al.. (2018). One-step pathway to selenoisobenzofuran-1(3H)-imine derivatives through highly selective selenocyclization of olefinic amides with benzeneselenyl chloride. Organic & Biomolecular Chemistry. 16(12). 2150–2155. 9 indexed citations

20.

Yang, Lu, Qiuyu Meng, Zhiye Hu, et al.. (2018). Estrogen receptor sensing in living cells by a high affinity turn-on fluorescent probe. Sensors and Actuators B Chemical. 272. 589–597. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact